In this session: Craig Clifford, DVM, MS, DACVIM (Oncology), describes the latest in the field of oncology, including a chemotherapy sensitivity assay from Imprimed to help guide drug decisions, a new conditionally approved drug for canine lymphoma called Laverdia CA-1, and the use of the oncoK9 liquid biopsy test from PetDx.
This content is for members only. Visit the site and log in/register to read.